Visby Medical Stock
HealthTechLooking to sell Visby Medical stock or options?
Visby Medical develops PCR-based diagnostic testing devices aimed at detecting infectious diseases. Their innovative platform delivers PCR results in less than 30 minutes and eliminates the need for extra instruments or maintenance. This enables healthcare providers to diagnose and treat patients in a single visit, ultimately enhancing patient outcomes and minimizing the necessity for follow-up appointments.
Nissim Capital, Highbury Group, Hutchison Port Group, Amplify Partners, Rheinest, Lightrock, Cambrian Growth Partners, CARB-X, Ling Wong, Ping An Voyager Partners, J-Ventures, Healthcare of Ontario Pension Plan, Blue Water Life Science Advisors, Cedars-Sinai, John Doerr, TDJ Pitango Ventures, E Squared Capital Management, 1809 Capital, Cedars Sinai Health Ventures, Omron Ventures, ND Capital, Dynamic Loop Capital, Artiman Ventures, Terrapin Partners, Pitango Venture Capital.